Nonetheless, the authors state that it should be avoided inthose who do not present a family history of cancer or multiple primary tumors, mainly dueto the low estimated prevalence of positive cases in this category (less than 5%) and thepsychosocial burden induced by a TP53 genetic testing. The gene discussed is TP53; the disease is cancer.